Incentives for pharmaceutical innovation : what's working, what's lacking
Year of publication: |
2022
|
---|---|
Authors: | Kyle, Margaret K. |
Published in: |
International journal of industrial organization. - Amsterdam [u.a.] : Elsevier, ISSN 0167-7187, ZDB-ID 875355-6. - Vol. 84.2022, p. 1-13
|
Subject: | Innovation | Pharmaceuticals | Health | COVID | Pharmaindustrie | Pharmaceutical industry | Arzneimittel | Pharmakologie | Pharmacology | Innovationsmanagement | Innovation management | Produktentwicklung | New product development | Gesundheitspolitik | Health policy | Coronavirus | Anreiz | Incentives |
-
An optimal mechanism to fund the development of vaccines against emerging epidemics
Snyder, Christopher M., (2023)
-
Rushed innovation : evidence from drug licensing
Hermosilla, Manuel, (2021)
-
Private versus social incentives for pharmaceutical innovation
González, Paula, (2015)
- More ...
-
Berger, Allen N., (2000)
-
Investments in Pharmaceuticals Before and After TRIPS
Kyle, Margaret K., (2012)
-
Investments in Pharmaceuticals Before and After TRIPS
Kyle, Margaret K., (2009)
- More ...